Christine Mundkur

Christine Mundkur

Director/Board Member at MANNKIND CORPORATION

Net worth: 2 M $ as of 2026-06-29

57 year
Health Technology
Consumer Services
Distribution Services

Profile

Christine Ann Mundkur currently serves as Independent Director at Cardinal Health, Inc. since 2022 and at MannKind Corp.
since 2018.
Ms. Mundkur is also a Director at Lupin Pharmaceuticals, Inc., Nanomi BV, and Lupin, Inc. Former positions include President & CEO-North America at Sandoz, Inc. from 2009 to 2010, Chief Executive Officer at Barr Laboratories, Inc. in 2008, Chairman & Chief Executive Officer at Impopharma, Inc. from 2013 to 2017, Independent Non-Executive Director at Lupin Ltd. from 2019 to 2023, Director at Uman Pharma, Inc., and SEVP-Global Quality, Safety & Regulatory Affairs at Barr Pharmaceuticals, Inc. from 1993 to 2008.
Education includes undergraduate studies at St. Louis University and a graduate degree from Saint Louis University School of Law conferred in 1993.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-11-04 7,536 ( 0% ) 2 M $ 2026-06-29
2026-05-19 27,675 ( 0.01% ) 117 896 $ 2026-06-29

Christine Mundkur active positions

CompaniesPositionStart
MANNKIND CORPORATION Director/Board Member 2018-11-26
CARDINAL HEALTH, INC. Director/Board Member 2022-09-05
Director/Board Member -
Director/Board Member -
Director/Board Member -

Former positions of Christine Mundkur

CompaniesPositionEnd
LUPIN LIMITED Director/Board Member 2022-12-31
Chief Executive Officer 2017-01-31
President 2010-03-31
Chief Executive Officer 2008-11-30
░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Christine Mundkur's experience

Training of Christine Mundkur

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Christine Mundkur